BRCA2 and cancer: These findings were in lines with previous reports that oxaliplatin killed cells by inducing ribosome biogenesis stress (18) and knockdown of genes involved in mitotic spindle and G2/M checkpoint, such as BRCA2, efficiently sensitized cancer cells to oxaliplatin treatment (27).